Zicam Swab Platform Takes Center Stage In Matrixx Growth Plans
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives plans to introduce more products delivered via the swab platform used in one of the Zicam nasal products that FDA advised the firm to recall in 2009